Search | WHO COVID-19 Research Database

Engelures associées au COVID : plus de lien de causalité avec le virus SARS-CoV-2 et moins d'évidence pour une réponse systémique augmentée de l'interféron de type 1

Bessis, D.; Trouillet-Assant, S.; Secco, L.; Blatière, V.; Girard, C.; Molinari, N.; Pallure, V.; Peyron, N. R.; Schwob, E.; Pescarmona, R.; Samaran, Q.; Vincent, T.; Sofonea, M.; Belot, A.; Tuaillon, É.

Annales de Dermatologie et de Vénéréologie - FMC ; 2(8):A126, 2022.

Article in English | PubMed Central | ID: covidwho-2158825

Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19.

Fougerousse, A-C; Perrussel, M; Bécherel, P-A; Begon, E; Pallure, V; Zaraa, I; Chaby, G; Parier, J; Kemula, M; Mery-Bossard, L; Poreaux, C; Taieb, C; Maccari, F; Reguiai, Z.

J Eur Acad Dermatol Venereol ; 34(11): e676-e679, 2020 Nov.

Article in English | MEDLINE | ID: covidwho-609405

Subject(s)

Biological Products/therapeutic use , COVID-19/complications , Dermatologic Agents/therapeutic use , Psoriasis/therapy , Adult , Aged , COVID-19 Testing , Comorbidity , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , SARS-CoV-2 , Telemedicine

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL